IP Library › Granted Patent US 9,802,987
Granted Patent B2
US 9,802,987 · App. 14/773,324 · Granted Oct 31, 2017

Immunogenic fusion polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,802,987
App. No.
14/773,324
Granted
Oct 31, 2017
Kind
B2
Abstract

In one aspect, the invention relates to an isolated polypeptide including the amino acid sequence of a carrier polypeptide and the amino acid sequence of an ORF2086 polypeptide. In another aspect, the invention relates to an immunogenic conjugate including ORF2086 polypeptide and a carrier polypeptide. The invention further includes immunogenic compositions and methods for inducing an immune response against Neisseria meningitidis in a mammal.

Claims (6)

1. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 2.

2. The isolated polypeptide according to claim 1 , wherein the amino acid sequence is encoded by SEQ ID NO: 4.

3. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 8.

4. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 14.

5. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 16.

6. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 18.

Assignments (1)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 20, 2023
From: PFIZER INC.
To: PFIZER INC.
Reel/Frame 063119/0087 →